During the past decade, Dr Robert Wallace conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr Robert Wallace" are "HIV Infections" (3 trials) and "Mycobacterium Avium-intracellulare Infection" (1 trials). Many other conditions were trialed in "Dr Robert Wallace" in a lesser frequency.

Most popular intervention types in "Dr Robert Wallace" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Azithromycin" (1 trials), "Clarithromycin" (1 trials), "Didanosine" (1 trials), "Emivirine" (1 trials) and "Emtricitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr Robert Wallace" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dr Robert Wallace". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dr Robert Wallace, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr Robert Wallace, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".